244 related articles for article (PubMed ID: 27333030)
1. Repurposing Cationic Amphiphilic Antihistamines for Cancer Treatment.
Ellegaard AM; Dehlendorff C; Vind AC; Anand A; Cederkvist L; Petersen NHT; Nylandsted J; Stenvang J; Mellemgaard A; Østerlind K; Friis S; Jäättelä M
EBioMedicine; 2016 Jul; 9():130-139. PubMed ID: 27333030
[TBL] [Abstract][Full Text] [Related]
2. Antihistamines and Ovarian Cancer Survival: Nationwide Cohort Study and in Vitro Cell Viability Assay.
Verdoodt F; Dehlendorff C; Jäättelä M; Strauss R; Pottegård A; Hallas J; Friis S; Kjaer SK
J Natl Cancer Inst; 2020 Sep; 112(9):964-967. PubMed ID: 31688928
[TBL] [Abstract][Full Text] [Related]
3. Cationic amphiphilic antihistamines inhibit STAT3 via Ca
Liu B; Chen R; Zhang Y; Huang J; Luo Y; Rosthøj S; Zhao C; Jäättelä M
Cell Rep; 2023 Feb; 42(2):112137. PubMed ID: 36807142
[TBL] [Abstract][Full Text] [Related]
4. Cell Death Induced by Cationic Amphiphilic Drugs Depends on Lysosomal Ca
Anand A; Liu B; Dicroce Giacobini J; Maeda K; Rohde M; Jäättelä M
Mol Cancer Ther; 2019 Sep; 18(9):1602-1614. PubMed ID: 31285280
[TBL] [Abstract][Full Text] [Related]
5. Comparative analysis of the cardiotoxicity proclivities of second generation antihistamines in an experimental model predictive of adverse clinical ECG effects.
Hey JA; del Prado M; Sherwood J; Kreutner W; Egan RW
Arzneimittelforschung; 1996 Feb; 46(2):153-8. PubMed ID: 8720304
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of cationic amphiphilic antihistamines on outcomes of patients treated with immune checkpoint inhibitors.
Chiang CH; Chiang CH; Peng CY; Hsia YP; See XY; Horng CS; Chang YC; Shen XE; Wang SS; Tsai TC; Chen YJ; Ma KS; Chen BS; Luan YZ; Tay ST; Shen CH; Chung KC; Chiang CH; Peng CM
Eur J Cancer; 2022 Oct; 174():1-9. PubMed ID: 35964360
[TBL] [Abstract][Full Text] [Related]
7. Variations among non-sedating antihistamines: are there real differences?
Mattila MJ; Paakkari I
Eur J Clin Pharmacol; 1999 Apr; 55(2):85-93. PubMed ID: 10335901
[TBL] [Abstract][Full Text] [Related]
8. Desloratadine and loratadine stand out among common H
Fritz I; Wagner P; Broberg P; Einefors R; Olsson H
Acta Oncol; 2020 Sep; 59(9):1103-1109. PubMed ID: 32459128
[TBL] [Abstract][Full Text] [Related]
9. Histamine Receptor Antagonists, Loratadine and Azelastine, Sensitize P-gp-overexpressing Antimitotic Drug-resistant KBV20C Cells Through Different Molecular Mechanisms.
Kim JY; Kim KS; Kim IS; Yoon S
Anticancer Res; 2019 Jul; 39(7):3767-3775. PubMed ID: 31262903
[TBL] [Abstract][Full Text] [Related]
10. The Efficacy of Cationic Amphiphilic Antihistamines on Outcomes of Patients with Pancreatic Ductal Adenocarcinoma.
Chiang CH; Chiang CH; Hsia YP; Chen BS; Jaroenlapnopparat A; Chiang CH; Peng CM
J Gastrointest Cancer; 2024 Mar; 55(1):175-177. PubMed ID: 37707624
[TBL] [Abstract][Full Text] [Related]
11. The new H1 antihistamines. Treatment of urticaria and other clinical problems.
Goldsmith P; Dowd PM
Dermatol Clin; 1993 Jan; 11(1):87-95. PubMed ID: 8094649
[TBL] [Abstract][Full Text] [Related]
12. A parallel-group comparison of astemizole and loratadine for the treatment of perennial allergic rhinitis.
al-Muhaimeed H
J Int Med Res; 1997; 25(4):175-81. PubMed ID: 9283989
[TBL] [Abstract][Full Text] [Related]
13. The effects of astemizole, cetirizine and loratadine on the time course of weal and flare reactions to histamine, codeine and antigen.
Humphreys F; Hunter JA
Br J Dermatol; 1991 Oct; 125(4):364-7. PubMed ID: 1683252
[TBL] [Abstract][Full Text] [Related]
14. EHD1 confers resistance to cisplatin in non-small cell lung cancer by regulating intracellular cisplatin concentrations.
Gao J; Meng Q; Zhao Y; Chen X; Cai L
BMC Cancer; 2016 Jul; 16():470. PubMed ID: 27411790
[TBL] [Abstract][Full Text] [Related]
15. Comparative efficacy of terfenadine, loratadine, and astemizole in perennial allergic rhinitis.
Crawford WW; Klaustermeyer WB; Lee PH; Placik IM
Otolaryngol Head Neck Surg; 1998 May; 118(5):668-73. PubMed ID: 9591867
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the effects of loratadine and astemizole in the treatment of children with seasonal allergic rhinoconjunctivitis.
Boner AL; Richelli C; Castellani C; Marchesi E; Andreoli A
Allergy; 1992 Apr; 47(2 Pt 1):98-102. PubMed ID: 1385929
[TBL] [Abstract][Full Text] [Related]
17. [The effect of second generation histamine antagonists on the heart].
Grzelewska-Rzymowska I; Pietrzkowicz M; Górska M
Pneumonol Alergol Pol; 2001; 69(3-4):217-26. PubMed ID: 11575008
[TBL] [Abstract][Full Text] [Related]
18. Development of pharmaceutically scalable inhaled anti-cancer nanotherapy - Repurposing amodiaquine for non-small cell lung cancer (NSCLC).
Parvathaneni V; Kulkarni NS; Chauhan G; Shukla SK; Elbatanony R; Patel B; Kunda NK; Muth A; Gupta V
Mater Sci Eng C Mater Biol Appl; 2020 Oct; 115():111139. PubMed ID: 32600728
[TBL] [Abstract][Full Text] [Related]
19. The role of H1 antihistamines in contralateral breast cancer: a Danish nationwide cohort study.
Bens A; Dehlendorff C; Friis S; Cronin-Fenton D; Jensen MB; Ejlertsen B; Lash TL; Kroman N; Mellemkjær L
Br J Cancer; 2020 Mar; 122(7):1102-1108. PubMed ID: 32063603
[TBL] [Abstract][Full Text] [Related]
20. EZH2 inhibitors reverse resistance to gefitinib in primary EGFR wild-type lung cancer cells.
Gong H; Li Y; Yuan Y; Li W; Zhang H; Zhang Z; Shi R; Liu M; Liu C; Chen C; Liu H; Chen J
BMC Cancer; 2020 Dec; 20(1):1189. PubMed ID: 33276757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
